US3707967A - Steady flow regenerative peritoneal dialysis system and method - Google Patents

Steady flow regenerative peritoneal dialysis system and method Download PDF

Info

Publication number
US3707967A
US3707967A US00077240A US3707967DA US3707967A US 3707967 A US3707967 A US 3707967A US 00077240 A US00077240 A US 00077240A US 3707967D A US3707967D A US 3707967DA US 3707967 A US3707967 A US 3707967A
Authority
US
United States
Prior art keywords
fluid
flow
dialysate
conduits
means includes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00077240A
Inventor
S Kitrilakis
T Robinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tecna Corp
Wells Fargo Bank NA
Original Assignee
Tecna Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecna Corp filed Critical Tecna Corp
Application granted granted Critical
Publication of US3707967A publication Critical patent/US3707967A/en
Assigned to CROCKER NATIONAL BANK reassignment CROCKER NATIONAL BANK ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: THORATEC LABORATORIES CORPORATION A CA CORP.
Assigned to CROCKER NATIONAL BANK reassignment CROCKER NATIONAL BANK SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THORATEC LABORATORIES CORPORATION A CA CORP
Assigned to WELLS FARGO BANK N.A. reassignment WELLS FARGO BANK N.A. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOTEX INDUSTRIES INCORPORATED MERCOR INCORPORATED, THORATEC LABORATORIES INCORPORATED, THORATEC MEDICAL INCORPORATED
Assigned to GLENN, PAUL F., BELL, CHRISTY W., BRADLEY RESOURCES COMPANY, A NEW YORK GENERAL PARTNERSHIP reassignment GLENN, PAUL F. SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THORATEC LABORATORIES CORPORATION, A CORP. OF CA.
Assigned to GLENN, PAUL F., ( GLENN ), BRADLEY RESOURCES COMPANY ("BRADLEY"), A NEW YORK GENERAL PARTNERSHIP, BELL, CHRISTY W., ( BELL ) reassignment GLENN, PAUL F., ( GLENN ) SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THORATEC LABORATORIES CORPORATION, A CA CORP.
Anticipated expiration legal-status Critical
Assigned to HILL, J. DONALD, BELL, CHRISTY W., BRADLEY RESOURCES COMPANY, GLENN, PAUL F. reassignment HILL, J. DONALD SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/1674Apparatus for preparing dialysates using UV radiation sources for sterilising the dialysate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1694Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid
    • A61M1/1696Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes with recirculating dialysing liquid with dialysate regeneration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/281Instillation other than by gravity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/282Operational modes
    • A61M1/284Continuous flow peritoneal dialysis [CFPD]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285Catheters therefor

Definitions

  • ATTORNEYS quantity of dialysing STEADY FLOW REGENERATIVE PERITONEAL DIALYSIS SYSTEM AND METHOD BACKGROUND OF THE INVENTION for treatment of chronic kidney disease.
  • Two types of lo dialysis are currently in use; hemodialysis and peritoneal dialysis.
  • hemodialysis the blood is removed from an artery or vein, dialyzed in an artifical kidney machine external of the body and returned to a vein usually through cannulas in the arm or leg.
  • This type if dialysis involves permanent connectors to major blood vessels for attachment of the device and also requires the handling of blood in an external prothesis.
  • the second type of dialysis which does not involve handling of blood directly in a prosthesis is peritoneal dialysis.
  • dialysing fluid is introduced in the abdominal cavity either through a puncture in the abdominal wall or through a permanently installed percutaneous tube.
  • the dialysate resides in the cavity for a period of time minutes to 1 hour) and is then removed. While the fluid is in the cavity, it picks up urea and other metabolic wastes from the blood stream by diffusion through the walls of the blood vessels within the abdominal cavity.
  • This scheme of dialysis avoids the requirement of handling the blood and invasion of the vascular system but requires the penetration of the abdominal wall. Both types of dialysis require that the blood stream be brought directly or indirectly in chemical equilibrium with a very large quantity of dialysate.
  • a dialysis system including in-flow and outflow conduits extending through the abdominal wall and provided with a surface which permits the growing and attachment of tissue to the surface of the conduits.
  • the conduits provide means for introducing and removing fluid from the peritoneal cavity which communicates with means for circulating the dialysate fluid through the cavity and regenerative means for regenerating the fluid.
  • the cavity, associated conduits, and circulating and regenerating means are connected in a closed fluid system whereby the fluid is continuously reconstituted and circulated through the peritoneal cavity.
  • FIG. 1 is a schematic diagram of the regenerative peritoneal dialysis system in accordance with the present invention shown connected to supply fluid to the cavity.
  • FIG 2 is an enlarged view of the abdominal wall showing the skin, subcutaneous tissue and peritoneum together with a conduit anchored in the wall by tissue growth.
  • FIG. 3 is an enlarged view of the portion of the conduit of FIG. 2 showing the surface microcavities into which the tissue grows.
  • FIG. 4 is a detailed drawing of the fluid circulating flow control and regeneration means.
  • microcavities which have a depth in the range of 0.002 to 0.020 inches. These microcavities permit the subcutaneous tissue to grow around the outside walls and become permanently affixed or anchored to the walls. Thus, the track along the peritoneal penetrations is completely sealed by the tissue which grows into the microcavities and is nourished from adjacent cells.
  • the tubes are preferably very small in diameter, for example, 1 to 3 mm. in diameter, and are very flexible because of the very low flow rates required in steady flow dialysis in accordance with another feature of the present invention. Both of these characteristics greatly facilitate the permanent fixation of the tubes into the abdominal wall.
  • the conduits 11 and 12 each have a portion 16 and 17, respectively, which extend into the abdominal cavity.
  • the other end of the conduit 12 is connected to means for removing the fluid from the abdominal cavity comprises a conduit 18 which, in turn, connects the pump 19 which serves to transport fluid from the upper portion of the abdominal cavity and pumps the fluid along the conduit2l to the reconstitution system 22 which reconstitutes the dialysate fluid and forms a means for supplying the fluid to the abdominal cavity.
  • the fluid then flows through the conduit 23 through the conduit 11 and into'the lower portionof the abdominal cavity at the tube 16.
  • the out-flow from'the peritoneal cavity flows along the line 18 to the fluid pump 19.
  • the pump 19 may include a cup-shaped chamber 26 provided with a cap 27 which is suitably secured to the portion 26 as, for example, by screws.
  • Piston 28 which includes a pair of spaced ports 29 provided with one-way valves 31 is disposed in the chamber 26.
  • the piston is urged in one as by a ring 36 and its other end suitably secured to the cup by being sandwiched between the cap 27 and the side walls 26;
  • fluid is drawn into the chamber 33 as the springs urge the piston in one direction.
  • the fluid in the upper chamber 39 which is defined by the other side of the piston, the flexible seal membrane 34 and a second sealing membrane 40, is moved through the conduit 21 into the reconstitution system.
  • the upper chamber 39 is defined by the upper wall of the pump together with the flexible seal 36 which has one end affixed to the upper wall by means of a ring 41 and to the piston rod by means of a second ring 42.
  • the reconstitution system may be one of two general types.
  • a first type illustrated in FIGS. 1 and 4
  • the fluid travelling along the conduit 21 passes through a urea removal column 46, an activated carbonor charcoal column 47, a transparent conduit portion 48 which is irradiated by an ultra-violet source 49, and a conventional flow regulator 50 which regulates the flow and finally through a filter 51.
  • the reconstituted fluid leaving the reconstitution system is thenapplied along the conduit 23 to the in-flow conduit 11.
  • the rate of flow through the system is controlledby flow regulator 50.
  • the chamber 33 is full and, of course, chamber 39 is basically empty.
  • the piston is then depressed and fluid is transferred from the lower chamber 33 to the upper chamber 34, through valve means 31.
  • the piston is released and the springs urge thepiston upwardly pumping fluid into the chamber and expelling fluid from the chamber 39.
  • the urea removal column includes material which serves to absorb urea or converts the urea to ammonia enzymatically as with the enzyme, urease, and then absorbs the ammonia. Such columns are known.
  • An activated carbon column may be used to absorb creatinine, uric acid and other toxic substances.
  • the ultraviolet sterilizer is used to sterilize the dialysate and prevent bacterial growth.
  • the filter may be of a type which can or cannot pass bacteria depending upon the effectiveness of the ultra-violet sterilizer and sterilizing procedures. It, of course, will trap larger particles and prevent them from entering into the abdominal cavity where they may be a source of tissue irritation and adhesions.
  • the filter, flow regulator, sterilizer, transparentwindow and reconstitution columns form a selfcontained package which may or may not include the pump and which can easily be replaced.
  • dialysate of the order of one liter or less,'and the fact that this same'amount of dialysate is continuously reconstituted permits use of a steady flow and possibly a continuous dialysis process.
  • the system is of relatively small size because of the small volume of dialysate fluid being used which makes it possible to devise a system which can be made portable and worn in the vicinity of the patients waist.
  • the patient can be completely rehabilitated by wearing such a system. He can continue to perform his normal tasks while dialysis is taking place. This is very much like a physiologic process performed by the kidneys.
  • a second type of reconstitution system which is conventional in the dialysis field, essentially all of the material removed from the abdominal cavity is non-selectively eliminated from the dialysate fluid.
  • Those components removed during dialysis which are desirable to replace, such as glucose, the ions of sodium, calcium and potassium are supplied to the in-flow conduit from a source external to the reconstitution system.
  • Such systems include the electrolytic type as described in S. B. Tuwiner, Research Design and Development of an Improved Water Reclamation System for Manned Space Vehicles (April 1966), Report No. NASA CR66323, and the ion exchange type as described in R. D. Fall et al., Feasibility of Microcapsule System for Artifical Kidney Applications, Annual Report by Battelle Memorial Institute (Dec. 1968).
  • a simplified technique for supplying dialysate fluid to the abdominal cavity and removing the fluid from the same eliminates the need for any reconstitution system.
  • the dialysate fluid is supplied from a fresh external source along with the aforementioned desirable components removed during dialysis.
  • the fluid removed from the abdominal cavity is directed to a waste sink.
  • the features that make this system possible and of considerable advantage over prior art systems are the use of the permanently implanted conduits which allow fluid to be introduced and removed from the peritoneal cavity, the reconstitution system which permits the same fluid to be recycled after the waste that is picked up in the peritoneal cavity has been removed, and the simple system for sterilizing and pumping the fluid through the regeneration system and back to the abdominal cavity.
  • flow rate also permits effective ultra-violet sterilization and ultrafiltration to be accomplished.
  • a steady flow peritoneal dialysis system including in-flow and out-flow conduits adapted to extend through the abdominal wall into the abdominal cavity whereby dialysate fluid may be introduced into and removed from the cavity, each of said conduits including an external surface portion at the interface between the abdominal wall and the conduits which is compatible with the skin, subcutaneous tissue and other tissue, said surface including a plurality of adjacent substantially discrete pockets having openings which face in the direction of said skin and tissue, the walls of said pocket extending inwardly to a depth in the range of 0.002 to 0.020 inches and being of such shape and size as to provide means to accommodate a number of living cells sufficient to provide anchorin but not solarge as to prevent essentially normal trans er of nutrients o the living cells in said pockets from adjacent skin and tissue, means for supplying the dialysate fluid to said inflow conduit, means for causing the dialysate fluid to flow through the cavity, and means for removing the dialysate fluid from said out-flow conduit.
  • a system as in claim I in whichsaid means for causing fluid to flow comprises a sealed pump.
  • said supply and removal means includes means for reconstituting the dialysate fluid connected by fluid conduits to said inflow and out-flow conduits.
  • a system as in claim 5 including means for irradiating the circulatory fluid with ultra-violet radiation.
  • said reconstitution means includes a filter adapted to receive the fluid flowing from the irradiation means.
  • a system as in claim 5 in which said system is a closed self-contained fluid system.

Abstract

A steady-flow regenerative peritoneal dialysis system and method making use of permanent percutaneous tubes extending into the abdominal cavity and means for circulating a dialysate through the abdominal cavity and reconstituting the dialysate.

Description

United States Patent 1-19 Kitrilakis et al. [4 1 Jan. 2, 1973 s41 STEADY FLOW REGENERATIVE 3,520,298 7/1970 Lange ..l28/213 PERITONEAL DIALYSIS SYSTEM AN 3,545,438 12/1910 De Vries ..12s/21s METHOD OTHER PUBLICATIONS [75] Inventors: soflfis Kimhkis' Berkele Thom Gordon et 21]., Trans. Amer. Soc. Artif. Inter. Organs Charles Robinson, E1 Cemto, both of Calif Vol. XV, 1969 (June) pp. 347-352.
Shinaberger et al., Trans. Amer. Soc. Artif. Inter. Or- [73] Assignee: Teena Corporation, Berkeley, Calif. gang Vol, X1, 1965 pp, 76-81. [22] Filed: Oct 1, 1970 Ersek et al., Trans. Amer. Soc. Artif. lnter. Organs 4 Vol. XV, 1969, pp. 267-271. [21] Appl. No.: 77,240
' Primary Examiner-Dalton L. Truluck [52] US. Cl. ..128/213, 128/348 y Hohbach, Test, Albritton & Herbert [51] Int. Cl. ..A6lm 5/00 58 Field of Search ..128/213, 214 R, 348, 1 R; 7] ABST 210/32 A steady-flow regenerative peritoneal dialysis system and method making use of permanent percutaneous [56] References cued tubes extending into the abdominal cavity and means UNITED STATES PATENTS for circulating a dialysate through the abdominal cavity and reconstituting the dialysate. 3,314,420 4/1967 Smith et al ..l28/92 C 3,605,123 9/1971 Hahn .311 9 Claims, 4 Drawing Figures REGENERATION 22 1? INFLOW [I I l 19 '1 PUMP f f OUTFLO u.v. STERILIZER UREA REMOVAL COLUMN FILTER FLOW REOUIATOR ORIFICE ACTIVATED CARBON I //7/1, 36v 29- I9 I 32 l I II A l SOTIRIS KITRILAKIS THOMAS C. ROBINSON INVENTORS BY 224, M 721, 4 4125 "4%:
ATTORNEYS quantity of dialysing STEADY FLOW REGENERATIVE PERITONEAL DIALYSIS SYSTEM AND METHOD BACKGROUND OF THE INVENTION for treatment of chronic kidney disease. Two types of lo dialysis are currently in use; hemodialysis and peritoneal dialysis. In hemodialysis the blood is removed from an artery or vein, dialyzed in an artifical kidney machine external of the body and returned to a vein usually through cannulas in the arm or leg. This type if dialysis involves permanent connectors to major blood vessels for attachment of the device and also requires the handling of blood in an external prothesis.
The second type of dialysis which does not involve handling of blood directly in a prosthesis is peritoneal dialysis. In this method, dialysing fluid is introduced in the abdominal cavity either through a puncture in the abdominal wall or through a permanently installed percutaneous tube. The dialysate resides in the cavity for a period of time minutes to 1 hour) and is then removed. While the fluid is in the cavity, it picks up urea and other metabolic wastes from the blood stream by diffusion through the walls of the blood vessels within the abdominal cavity. This scheme of dialysis avoids the requirement of handling the blood and invasion of the vascular system but requires the penetration of the abdominal wall. Both types of dialysis require that the blood stream be brought directly or indirectly in chemical equilibrium with a very large quantity of dialysate. In addition to the waste material picked up by the dialysate, a certain amount of proteins and inorganic constituents capable of diffusing through the hemodialysis membrane or the blood vessel walls are dissolved in the dialysate fluid and lost. The systemic replacement capacity for these substances may or may not be capable of maintaining physiologic levels. When certain of these materials are depleted by chronic dialysis over long periods of time, characteristic pathologic symptoms often appear. The depletion of important trace components is proportional to the total quantity of dialysate used.
An additional serious difficulty with both types of dialysis is the danger of infection, either at the sites of cannulation of arteries and veins in the case of hemodialysis, or the penetrations through the abdominal wall, temporary or permanent, in the case of peritoneal dialysis. The large quantities of dialysate involved must be maintained sterile during preparation and throughout the diffusion process to avoid infecting the blood stream or the peritoneal cavity.
As a consequence, elaborate cleaning and sterilization procedures must be followed by hospital personnel or the patient himself while connecting the cannulas or percutaneous in-flow out-flow tubes to the dialysis equipment. Any laxities during the procedure can lead to serious infection.
The equipment involved in both types dialysis is bulky and expensive, primarily because of the large fluid and the handling of blood. In both types the patient must be attached to the equipment and remains essentially immobilized for the duration of the dialysis process. The complexity and high risks associated with currently used dialysis equipment and methods have resulted in the administration of treatments as infrequently as possible, usually about 2-3 times weekly. In the time period between treatments the concentration of metabolic wastes in the patients blood stream continuously increases reaching levels which normally cause discomfort and often clebilitation prior to the next dialysis treatment.
The discomfort and incapacity prior and during treatments often impairs the patients ability to lead a normal, productive life and may also lead to serious psychological problems.
OBJECTS AND SUMMARY OF THE INVENTION It is a general object of the present invention to provide a steady-flow regenerative peritoneal dialysis system and method which overcomes a number of the drawbacks of presently used systems and methods.
It is another object of the present invention to provide a peritoneal dialysis system and method which employs a small amount of dialysate fluid which is circulated at low, steady flow rates through the peritoneal cavity via in-flow and out-flow tubes extending through the abdominal wall.
\ It is another object of the present invention to provide a regenerative peritoneal dialysis system and method wherein the fluid employed is regenerated and the amount retained in the abdomen is minimized whereby the abdominal cavity is not distended by a large amount of fluid and virtually no discomfort results from'the presence of the fluid within the cavity.
It is a further object of the present invention to provide a peritoneal dialysis system and method in which the dialysis is performed at steady flow rates and approaches continuous use thereby eliminating excessive concentrations or urea and other metabolic wastes which would otherwise build up in the blood stream and thereby avoid abrupt changes in waste concentration resulting from present dialysis processes.
It is a further object of the present invention to provide a continuous regenerative peritoneal dialysis system and method in which the in-flow and out-flow tubes extending through the abdominal wall into the peritoneal cavity are permanently affixed and are formed whereby the tissue may readily grow to the surface of the tubes to form a living seal to prevent bacterial infection.
The foregoing and other objects of the invention are achievedby a dialysis system including in-flow and outflow conduits extending through the abdominal wall and provided with a surface which permits the growing and attachment of tissue to the surface of the conduits. The conduits provide means for introducing and removing fluid from the peritoneal cavity which communicates with means for circulating the dialysate fluid through the cavity and regenerative means for regenerating the fluid. The cavity, associated conduits, and circulating and regenerating means are connected in a closed fluid system whereby the fluid is continuously reconstituted and circulated through the peritoneal cavity.
BRIEF DESCRIPTION OF THE DRAWINGS I FIG. 1 is a schematic diagram of the regenerative peritoneal dialysis system in accordance with the present invention shown connected to supply fluid to the cavity.
FIG 2 is an enlarged view of the abdominal wall showing the skin, subcutaneous tissue and peritoneum together with a conduit anchored in the wall by tissue growth.
FIG. 3 is an enlarged view of the portion of the conduit of FIG. 2 showing the surface microcavities into which the tissue grows.
FIG. 4 is a detailed drawing of the fluid circulating flow control and regeneration means.
DESCRIPTION OF THE PREFERRED EMBODIMENTS vide microcavities which have a depth in the range of 0.002 to 0.020 inches. These microcavities permit the subcutaneous tissue to grow around the outside walls and become permanently affixed or anchored to the walls. Thus, the track along the peritoneal penetrations is completely sealed by the tissue which grows into the microcavities and is nourished from adjacent cells.
The tubes are preferably very small in diameter, for example, 1 to 3 mm. in diameter, and are very flexible because of the very low flow rates required in steady flow dialysis in accordance with another feature of the present invention. Both of these characteristics greatly facilitate the permanent fixation of the tubes into the abdominal wall. The conduits 11 and 12 each have a portion 16 and 17, respectively, which extend into the abdominal cavity. The other end of the conduit 12 is connected to means for removing the fluid from the abdominal cavity comprises a conduit 18 which, in turn, connects the pump 19 which serves to transport fluid from the upper portion of the abdominal cavity and pumps the fluid along the conduit2l to the reconstitution system 22 which reconstitutes the dialysate fluid and forms a means for supplying the fluid to the abdominal cavity. The fluid then flows through the conduit 23 through the conduit 11 and into'the lower portionof the abdominal cavity at the tube 16. Thus, it is seen that there is formed a closed system in which the dialysate fluid is circulated and reconstituted.
The out-flow from'the peritoneal cavity flows along the line 18 to the fluid pump 19. The pump 19 may include a cup-shaped chamber 26 provided with a cap 27 which is suitably secured to the portion 26 as, for example, by screws. Piston 28 which includes a pair of spaced ports 29 provided with one-way valves 31 is disposed in the chamber 26. The piston is urged in one as by a ring 36 and its other end suitably secured to the cup by being sandwiched between the cap 27 and the side walls 26; Thus, fluid is drawn into the chamber 33 as the springs urge the piston in one direction. At the same time as fluid is being drawn into chamber 33, the fluid in the upper chamber 39, which is defined by the other side of the piston, the flexible seal membrane 34 and a second sealing membrane 40, is moved through the conduit 21 into the reconstitution system. The upper chamber 39 is defined by the upper wall of the pump together with the flexible seal 36 which has one end affixed to the upper wall by means of a ring 41 and to the piston rod by means of a second ring 42.
The reconstitution system may be one of two general types. In a first type, illustrated in FIGS. 1 and 4, the fluid travelling along the conduit 21 passes through a urea removal column 46, an activated carbonor charcoal column 47, a transparent conduit portion 48 which is irradiated by an ultra-violet source 49, and a conventional flow regulator 50 which regulates the flow and finally through a filter 51. The reconstituted fluid leaving the reconstitution system is thenapplied along the conduit 23 to the in-flow conduit 11. The rate of flow through the system is controlledby flow regulator 50.
After the piston P reaches the top of the stroke, the chamber 33 is full and, of course, chamber 39 is basically empty. The piston is then depressed and fluid is transferred from the lower chamber 33 to the upper chamber 34, through valve means 31. When the piston reaches its lowest stroke, the piston is released and the springs urge thepiston upwardly pumping fluid into the chamber and expelling fluid from the chamber 39.
Although rolling diaphragms or seals are indicated and are preferable since there is minimal leakage and a reliable method of knowing the piston displacement and rate and minimal friction, it is, of course, apparent that other seals such as O-ring seals or the like could be employed. In any event, the pump is entirely sealed and remains sterile. v
The urea removal column includes material which serves to absorb urea or converts the urea to ammonia enzymatically as with the enzyme, urease, and then absorbs the ammonia. Such columns are known.
An activated carbon column may be used to absorb creatinine, uric acid and other toxic substances. The ultraviolet sterilizer is used to sterilize the dialysate and prevent bacterial growth. The filter may be of a type which can or cannot pass bacteria depending upon the effectiveness of the ultra-violet sterilizer and sterilizing procedures. It, of course, will trap larger particles and prevent them from entering into the abdominal cavity where they may be a source of tissue irritation and adhesions. The filter, flow regulator, sterilizer, transparentwindow and reconstitution columns form a selfcontained package which may or may not include the pump and which can easily be replaced. The fact that a very small amount of dialysate is used, of the order of one liter or less,'and the fact that this same'amount of dialysate is continuously reconstituted permits use of a steady flow and possibly a continuous dialysis process. Further, the system is of relatively small size because of the small volume of dialysate fluid being used which makes it possible to devise a system which can be made portable and worn in the vicinity of the patients waist.
Thus, the patient can be completely rehabilitated by wearing such a system. He can continue to perform his normal tasks while dialysis is taking place. This is very much like a physiologic process performed by the kidneys.
In a second type of reconstitution system, not shown, which is conventional in the dialysis field, essentially all of the material removed from the abdominal cavity is non-selectively eliminated from the dialysate fluid. Those components removed during dialysis which are desirable to replace, such as glucose, the ions of sodium, calcium and potassium are supplied to the in-flow conduit from a source external to the reconstitution system. Such systems include the electrolytic type as described in S. B. Tuwiner, Research Design and Development of an Improved Water Reclamation System for Manned Space Vehicles (April 1966), Report No. NASA CR66323, and the ion exchange type as described in R. D. Fall et al., Feasibility of Microcapsule System for Artifical Kidney Applications, Annual Report by Battelle Memorial Institute (Dec. 1968).
A simplified technique for supplying dialysate fluid to the abdominal cavity and removing the fluid from the same eliminates the need for any reconstitution system. In this technique the dialysate fluid is supplied from a fresh external source along with the aforementioned desirable components removed during dialysis. The fluid removed from the abdominal cavity is directed to a waste sink.
In summary, the features that make this system possible and of considerable advantage over prior art systems are the use of the permanently implanted conduits which allow fluid to be introduced and removed from the peritoneal cavity, the reconstitution system which permits the same fluid to be recycled after the waste that is picked up in the peritoneal cavity has been removed, and the simple system for sterilizing and pumping the fluid through the regeneration system and back to the abdominal cavity.
The use of small amounts of fluid which are recycled has added advantages. Many of the abnormal side effects resulting from either hemodialysis or peritoneal dialysis with large volumes of fluid are avoided since this same fluid can be saturated with all those constituents which are normally depleted from the blood stream when a large amount of dialysate is used. Low
flow rate also permits effective ultra-violet sterilization and ultrafiltration to be accomplished.
We claim:
1. A steady flow peritoneal dialysis system including in-flow and out-flow conduits adapted to extend through the abdominal wall into the abdominal cavity whereby dialysate fluid may be introduced into and removed from the cavity, each of said conduits including an external surface portion at the interface between the abdominal wall and the conduits which is compatible with the skin, subcutaneous tissue and other tissue, said surface including a plurality of adjacent substantially discrete pockets having openings which face in the direction of said skin and tissue, the walls of said pocket extending inwardly to a depth in the range of 0.002 to 0.020 inches and being of such shape and size as to provide means to accommodate a number of living cells sufficient to provide anchorin but not solarge as to prevent essentially normal trans er of nutrients o the living cells in said pockets from adjacent skin and tissue, means for supplying the dialysate fluid to said inflow conduit, means for causing the dialysate fluid to flow through the cavity, and means for removing the dialysate fluid from said out-flow conduit.
2. A system as in claim I in whichsaid means for causing fluid to flow comprises a sealed pump.
3. A system as in claim 1 in which said supply and removal means includes a flow regulator.
4. A system as in claim 1 in whichsaid supply means includes a dialysate fluid source and said removal means includes a sink.
5. A system as in claim 1 in which said supply and removal means includes means for reconstituting the dialysate fluid connected by fluid conduits to said inflow and out-flow conduits.
6. A system as in claim 5 in which said reconstitution means includes a column for the removal of uric acid and creatinine.
7. A system as in claim 5 including means for irradiating the circulatory fluid with ultra-violet radiation.
8. A system as in claim 7 in which said reconstitution means includes a filter adapted to receive the fluid flowing from the irradiation means.
9. A system as in claim 5 in which said system is a closed self-contained fluid system.

Claims (9)

1. A steady flow peritoneal dialysis system including in-flow and out-flow conduits adapted to extend through the abdominal wall into the abdominal cavity whereby dialysate fluid may be introduced into and removed from the cavity, each of said conduits including an external surface portion at the interface between the abdominal wall and the conduits which is compatible with the skin, subcutaneous tissue and other tissue, said surface including a plurality of adjacent substantially discrete pockets having openings which face in the direction of said skin and tissue, the walls of said pocket extending inwardly to a depth in the range of 0.002 to 0.020 inches and being of such shape and size as to provide means to accommodate a number of living cells sufficient to provide anchoring but not so large as to prevent essentially normal transfer of nutrients to the living cells in said pockets from adjacent skin and tissue, means for supplying the dialysate fluid to said in-flow conduit, means for causing the dialysate fluid to flow through the cavity, and means for removing the dialysate fluid from said out-flow conduit.
2. A system as in claim 1 in which said means for causing fluid to flow comprises a sealed pump.
3. A system as in claim 1 in which said supply and removal means includes a flow regulator.
4. A system as in claim 1 in which said supply means includes a dialysate fluid source and said removal means includes a sink.
5. A system as in claim 1 in which said supply and removal means includes means for reconstituting the dialysate fluid connected by fluid conduits to said inflow and out-flow conduits.
6. A system as in claim 5 in which said reconstitution means includes a column for the removal of uric acid and creatinine.
7. A system as in claim 5 including means for irradiating the circulatory fluid with ultra-violet radiation.
8. A system as in claim 7 in which said reconstitution means includes a filter adapted to receive the fluid flowing from the irradiation means.
9. A system as in claim 5 in which said system is a closed self-contained fluid system.
US00077240A 1970-10-01 1970-10-01 Steady flow regenerative peritoneal dialysis system and method Expired - Lifetime US3707967A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7724070A 1970-10-01 1970-10-01

Publications (1)

Publication Number Publication Date
US3707967A true US3707967A (en) 1973-01-02

Family

ID=22136901

Family Applications (1)

Application Number Title Priority Date Filing Date
US00077240A Expired - Lifetime US3707967A (en) 1970-10-01 1970-10-01 Steady flow regenerative peritoneal dialysis system and method

Country Status (5)

Country Link
US (1) US3707967A (en)
JP (1) JPS528635B1 (en)
DE (1) DE2149040A1 (en)
GB (1) GB1307056A (en)
NL (1) NL7113434A (en)

Cited By (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160454A (en) * 1975-07-09 1979-07-10 University Of Utah Implantable catheter system
US4184497A (en) * 1977-08-26 1980-01-22 University Of Utah Peritoneal dialysis catheter
US4265760A (en) * 1979-02-26 1981-05-05 Becton Dickinson & Company Device for dilution and delivery of in vivo chemicals
US4381003A (en) * 1979-10-26 1983-04-26 Vincenzo Buoncristiani Method and apparatus for the automatic semicontinuous peritoneal dialysis
FR2515966A1 (en) * 1981-11-06 1983-05-13 Sord Orga Sarl Automatic peritoneal dialysis bag drainage control during treatment - using modules, each having corresponding clamp and hook arrangement, and UV sterilisation system
US4417888A (en) * 1982-03-15 1983-11-29 Renal Systems, Inc. Percutaneous implant
US4496349A (en) * 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
DE4001760A1 (en) * 1989-02-08 1990-08-09 Avl Medical Instr Ag DEVICE FOR DETERMINING AT LEAST ONE MEDICAL MEASURING SIZE
US5037385A (en) * 1988-10-24 1991-08-06 National Research Development Corporation Continuous ambulatory peritoneal dialysis method
US6245039B1 (en) * 1998-10-05 2001-06-12 Vasca, Inc. Methods and apparatus for performing flow-through peritoneal dialysis
US6409699B1 (en) 1996-10-22 2002-06-25 Renal Solutions, Inc. Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
WO2003030960A2 (en) * 2001-10-05 2003-04-17 Medical Components, Inc. Catheter for peritoneal dialysis
US6569130B1 (en) * 2001-04-12 2003-05-27 John M. Levin Chronic peritoneal dialysis sac
US6592542B2 (en) 2000-02-10 2003-07-15 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US20030220607A1 (en) * 2002-05-24 2003-11-27 Don Busby Peritoneal dialysis apparatus
US20030220598A1 (en) * 2002-05-24 2003-11-27 Don Busby Automated dialysis system
US6656227B2 (en) * 2000-10-20 2003-12-02 John M. Levin Prosthesis for internal peritoneal dialysis and method of providing peritoneal dialysis
US6666842B1 (en) * 1998-10-07 2003-12-23 Asahi Sakai Device and method for perfusing peritoneal dialyzing fluid
WO2004009156A2 (en) 2002-07-19 2004-01-29 Baxter International Inc. Systems and methods for peritoneal dialysis
US20040019320A1 (en) * 2002-07-19 2004-01-29 Childers Robert W. Systems and metods for performing peritoneal dialysis
US20040193098A1 (en) * 2001-10-05 2004-09-30 Angela Wentling Continuous flow peritoneal dialysis catheter
US6976973B1 (en) 2000-10-12 2005-12-20 Baxter International Inc. Peritoneal dialysis catheters
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US20070213665A1 (en) * 2006-03-08 2007-09-13 Conor Curtin Wearable kidney
US20080033346A1 (en) * 2002-12-31 2008-02-07 Baxter International Inc. Pumping systems for cassette-based dialysis
US20080051696A1 (en) * 2006-03-08 2008-02-28 Conor Curtin Artificial kidney dialysis system
US20090008306A1 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Extracorporeal dialysis ready peritoneal dialysis machine
US20090239821A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US20090281484A1 (en) * 2003-10-28 2009-11-12 Baxter International Inc. Peritoneal dialysis machine
US20090287178A1 (en) * 2008-05-13 2009-11-19 Herbert Curtis B Interosmolar fluid removal
US20100010429A1 (en) * 2002-07-19 2010-01-14 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US20100051552A1 (en) * 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
US20100114012A1 (en) * 2008-11-03 2010-05-06 Sandford Harold F Portable Peritoneal Dialysis System
US20100217179A1 (en) * 2009-02-20 2010-08-26 Baxter International Inc. Bulk delivery peritoneal dialysis system and method
US20100312172A1 (en) * 2009-06-06 2010-12-09 Hoffman Josef C A Method of Peritoneal Dialysis
WO2014159918A3 (en) * 2013-03-14 2015-04-16 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US20150273131A1 (en) * 2012-11-23 2015-10-01 Triomed Ab Phosphate and urea adsorption for dialysis
US20150290384A1 (en) * 2012-11-23 2015-10-15 Triomed Ab Adsorbent for dialysis
WO2015179329A1 (en) * 2014-05-19 2015-11-26 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
WO2015193880A1 (en) * 2014-06-15 2015-12-23 Yair Feld Continuous implantable peritoneal dialysis
US20160008529A1 (en) * 2014-07-11 2016-01-14 Josef C. A. Hoffman Peritoneal Dialysis System and Method
US9248221B2 (en) 2014-04-08 2016-02-02 Incuvate, Llc Aspiration monitoring system and method
US9433427B2 (en) 2014-04-08 2016-09-06 Incuvate, Llc Systems and methods for management of thrombosis
US9440017B2 (en) 2013-03-14 2016-09-13 Baxter International Inc. System and method for performing alternative and sequential blood and peritoneal dialysis modalities
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US9582645B2 (en) 2008-07-09 2017-02-28 Baxter International Inc. Networked dialysis system
US9675744B2 (en) 2002-05-24 2017-06-13 Baxter International Inc. Method of operating a disposable pumping unit
US9675745B2 (en) 2003-11-05 2017-06-13 Baxter International Inc. Dialysis systems including therapy prescription entries
US10226263B2 (en) 2015-12-23 2019-03-12 Incuvate, Llc Aspiration monitoring system and method
US10307564B2 (en) 2015-07-20 2019-06-04 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10426919B2 (en) 2015-07-20 2019-10-01 Strataca Systems Limited Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US10561440B2 (en) 2015-09-03 2020-02-18 Vesatek, Llc Systems and methods for manipulating medical devices
US10646634B2 (en) 2008-07-09 2020-05-12 Baxter International Inc. Dialysis system and disposable set
US10702292B2 (en) 2015-08-28 2020-07-07 Incuvate, Llc Aspiration monitoring system and method
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US11495334B2 (en) 2015-06-25 2022-11-08 Gambro Lundia Ab Medical device system and method having a distributed database
US11497521B2 (en) 2008-10-13 2022-11-15 Walk Vascular, Llc Assisted aspiration catheter system
US11510689B2 (en) 2016-04-06 2022-11-29 Walk Vascular, Llc Systems and methods for thrombolysis and delivery of an agent
US11516183B2 (en) 2016-12-21 2022-11-29 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
US11540847B2 (en) 2015-10-09 2023-01-03 Incuvate, Llc Systems and methods for management of thrombosis
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US11653945B2 (en) 2007-02-05 2023-05-23 Walk Vascular, Llc Thrombectomy apparatus and method
US11678905B2 (en) 2018-07-19 2023-06-20 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US11844891B2 (en) 2017-05-14 2023-12-19 Paragate Medical Ltd. Implantable fluid extraction system

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1558370A (en) * 1975-09-26 1979-12-28 Asahi Chemical Ind Blood treating apparatus
CA1124952A (en) * 1977-03-03 1982-06-08 Robert P. Popovich Method and apparatus for continuous, ambulatory peritoneal dialysis
DE2739350A1 (en) * 1977-09-01 1979-03-15 Schi Wa Arzneimittel DEVICE FOR TREATMENT OF URAEMIC PATIENTS
DE3147722C2 (en) * 1981-11-27 1985-02-28 Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg Peritoneal catheter
DD210385A3 (en) * 1982-06-28 1984-06-06 Medizin Labortechnik Veb K DIALYSIS DEVICE WITH REGENERATION SYSTEM FOR THE CONTINUOUS AMBULANT PERITONEAL DIALYSIS
US4747822A (en) * 1984-07-09 1988-05-31 Peabody Alan M Continuous flow peritoneal dialysis system and method
EP0243547B1 (en) * 1986-05-01 1991-07-24 Alan M. Peabody Continuous flow peritoneal dialysis apparatus
JPH02102934U (en) * 1989-02-02 1990-08-16

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314420A (en) * 1961-10-23 1967-04-18 Haeger Potteries Inc Prosthetic parts and methods of making the same
US3520298A (en) * 1967-08-10 1970-07-14 Kurt Lange Peritoneal dialysis apparatus
US3545438A (en) * 1968-02-12 1970-12-08 Sarns Inc Intermittent dialysis method and apparatus therefor
US3605123A (en) * 1969-04-29 1971-09-20 Melpar Inc Bone implant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3314420A (en) * 1961-10-23 1967-04-18 Haeger Potteries Inc Prosthetic parts and methods of making the same
US3520298A (en) * 1967-08-10 1970-07-14 Kurt Lange Peritoneal dialysis apparatus
US3545438A (en) * 1968-02-12 1970-12-08 Sarns Inc Intermittent dialysis method and apparatus therefor
US3605123A (en) * 1969-04-29 1971-09-20 Melpar Inc Bone implant

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Ersek et al., Trans. Amer. Soc. Artif. Inter. Organs Vol. XV, 1969, pp. 267 271. *
Gordon et al., Trans. Amer. Soc. Artif. Inter. Organs Vol. XV, 1969 (June) pp. 347 352. *
Shinaberger et al., Trans. Amer. Soc. Artif. Inter. Organs Vol. XI, 1965 pp. 76 81. *

Cited By (202)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160454A (en) * 1975-07-09 1979-07-10 University Of Utah Implantable catheter system
US4184497A (en) * 1977-08-26 1980-01-22 University Of Utah Peritoneal dialysis catheter
US4265760A (en) * 1979-02-26 1981-05-05 Becton Dickinson & Company Device for dilution and delivery of in vivo chemicals
US4381003A (en) * 1979-10-26 1983-04-26 Vincenzo Buoncristiani Method and apparatus for the automatic semicontinuous peritoneal dialysis
US4498900A (en) * 1979-10-26 1985-02-12 Vincenzo Buoncristiani Method for the automatic semicontinuous peritoneal dialysis
US4496349A (en) * 1981-05-08 1985-01-29 Renal Systems, Inc. Percutaneous implant
FR2515966A1 (en) * 1981-11-06 1983-05-13 Sord Orga Sarl Automatic peritoneal dialysis bag drainage control during treatment - using modules, each having corresponding clamp and hook arrangement, and UV sterilisation system
US4417888A (en) * 1982-03-15 1983-11-29 Renal Systems, Inc. Percutaneous implant
US5037385A (en) * 1988-10-24 1991-08-06 National Research Development Corporation Continuous ambulatory peritoneal dialysis method
DE4001760A1 (en) * 1989-02-08 1990-08-09 Avl Medical Instr Ag DEVICE FOR DETERMINING AT LEAST ONE MEDICAL MEASURING SIZE
AT393213B (en) * 1989-02-08 1991-09-10 Avl Verbrennungskraft Messtech DEVICE FOR DETERMINING AT LEAST ONE MEDICAL MEASURING SIZE
US5193545A (en) * 1989-02-08 1993-03-16 Avl Medical Instruments Ag Device for determining at least one medical variable
US6409699B1 (en) 1996-10-22 2002-06-25 Renal Solutions, Inc. Continuous flow-through peritoneal dialysis (CFPD) method with control of intraperitoneal pressure
US6245039B1 (en) * 1998-10-05 2001-06-12 Vasca, Inc. Methods and apparatus for performing flow-through peritoneal dialysis
US6585681B2 (en) 1998-10-05 2003-07-01 Vasca, Inc. Methods and apparatus for performing flow-through peritoneal dialysis
US20040087890A1 (en) * 1998-10-07 2004-05-06 Asahi Sakai Device and method for perfusing peritoneal dialyzing fluid
US6666842B1 (en) * 1998-10-07 2003-12-23 Asahi Sakai Device and method for perfusing peritoneal dialyzing fluid
US8206339B2 (en) 2000-02-10 2012-06-26 Baxter International Inc. System for monitoring and controlling peritoneal dialysis
US8172789B2 (en) 2000-02-10 2012-05-08 Baxter International Inc. Peritoneal dialysis system having cassette-based-pressure-controlled pumping
US9474842B2 (en) 2000-02-10 2016-10-25 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US6592542B2 (en) 2000-02-10 2003-07-15 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US20110028892A1 (en) * 2000-02-10 2011-02-03 Baxter International Inc. Peritoneal dialysis system having cassette-based-pressure-controlled pumping
US20030204162A1 (en) * 2000-02-10 2003-10-30 Childers Robert Warren Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US8323231B2 (en) 2000-02-10 2012-12-04 Baxter International, Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US20090198174A1 (en) * 2000-02-10 2009-08-06 Baxter International Inc. System for monitoring and controlling peritoneal dialysis
US7507220B2 (en) 2000-02-10 2009-03-24 Baxter International Inc. Method for monitoring and controlling peritoneal dialysis therapy
US10322224B2 (en) 2000-02-10 2019-06-18 Baxter International Inc. Apparatus and method for monitoring and controlling a peritoneal dialysis therapy
US20070135758A1 (en) * 2000-02-10 2007-06-14 Baxter International Inc. Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US20060004324A1 (en) * 2000-10-12 2006-01-05 Ruddell Scott A Peritoneal dialysis catheters
US7320674B2 (en) 2000-10-12 2008-01-22 Baxter International Inc. Peritoneal dialysis catheters
US6976973B1 (en) 2000-10-12 2005-12-20 Baxter International Inc. Peritoneal dialysis catheters
US20040049288A1 (en) * 2000-10-20 2004-03-11 Levin John M. Prosthesis for internal peritoneal dialysis and method of providing peritoneal dialysis
US6656227B2 (en) * 2000-10-20 2003-12-02 John M. Levin Prosthesis for internal peritoneal dialysis and method of providing peritoneal dialysis
US6569130B1 (en) * 2001-04-12 2003-05-27 John M. Levin Chronic peritoneal dialysis sac
US6911014B2 (en) 2001-10-05 2005-06-28 Medical Components, Inc. Continuous flow peritoneal dialysis catheter
WO2003030960A2 (en) * 2001-10-05 2003-04-17 Medical Components, Inc. Catheter for peritoneal dialysis
WO2003030960A3 (en) * 2001-10-05 2004-03-11 Medical Components Inc Catheter for peritoneal dialysis
US20040193098A1 (en) * 2001-10-05 2004-09-30 Angela Wentling Continuous flow peritoneal dialysis catheter
US6749580B2 (en) 2001-10-05 2004-06-15 Medical Components, Inc. Catheter
US7241272B2 (en) 2001-11-13 2007-07-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US10232103B1 (en) 2001-11-13 2019-03-19 Baxter International Inc. System, method, and composition for removing uremic toxins in dialysis processes
US20090314707A1 (en) * 2001-11-13 2009-12-24 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US20090301958A1 (en) * 2001-11-13 2009-12-10 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US20080011664A1 (en) * 2001-11-13 2008-01-17 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US8002726B2 (en) 2001-11-13 2011-08-23 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US8066658B2 (en) 2001-11-13 2011-11-29 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US10980931B2 (en) 2001-11-13 2021-04-20 Baxter International Inc. System, method, and composition for removing uremic toxins in dialysis processes
US20090218288A1 (en) * 2001-11-13 2009-09-03 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US7955290B2 (en) 2001-11-13 2011-06-07 Baxter International Inc. Method and composition for removing uremic toxins in dialysis processes
US8066671B2 (en) 2002-05-24 2011-11-29 Baxter International Inc. Automated dialysis system including a piston and stepper motor
US8403880B2 (en) 2002-05-24 2013-03-26 Baxter International Inc. Peritoneal dialysis machine with variable voltage input control scheme
US20030220607A1 (en) * 2002-05-24 2003-11-27 Don Busby Peritoneal dialysis apparatus
US20030220598A1 (en) * 2002-05-24 2003-11-27 Don Busby Automated dialysis system
US9504778B2 (en) 2002-05-24 2016-11-29 Baxter International Inc. Dialysis machine with electrical insulation for variable voltage input
US9511180B2 (en) 2002-05-24 2016-12-06 Baxter International Inc. Stepper motor driven peritoneal dialysis machine
US8684971B2 (en) 2002-05-24 2014-04-01 Baxter International Inc. Automated dialysis system using piston and negative pressure
US8529496B2 (en) 2002-05-24 2013-09-10 Baxter International Inc. Peritoneal dialysis machine touch screen user interface
US9675744B2 (en) 2002-05-24 2017-06-13 Baxter International Inc. Method of operating a disposable pumping unit
US20070213651A1 (en) * 2002-05-24 2007-09-13 Don Busby Automated dialysis pumping system using stepper motor
US20100087777A1 (en) * 2002-05-24 2010-04-08 Baxter International Inc. Peritoneal dialysis machine with variable voltage input control scheme
US8506522B2 (en) 2002-05-24 2013-08-13 Baxter International Inc. Peritoneal dialysis machine touch screen user interface
US10137235B2 (en) 2002-05-24 2018-11-27 Baxter International Inc. Automated peritoneal dialysis system using stepper motor
US7789849B2 (en) 2002-05-24 2010-09-07 Baxter International Inc. Automated dialysis pumping system using stepper motor
US7815595B2 (en) 2002-05-24 2010-10-19 Baxter International Inc. Automated dialysis pumping system
US10751457B2 (en) 2002-05-24 2020-08-25 Baxter International Inc. Systems with disposable pumping unit
US8376999B2 (en) 2002-05-24 2013-02-19 Baxter International Inc. Automated dialysis system including touch screen controlled mechanically and pneumatically actuated pumping
US20070149913A1 (en) * 2002-05-24 2007-06-28 Don Busby Automated dialysis pumping system
US20110040244A1 (en) * 2002-05-24 2011-02-17 Baxter International Inc. Automated dialysis system including a piston and stepper motor
US9744283B2 (en) 2002-05-24 2017-08-29 Baxter International Inc. Automated dialysis system using piston and negative pressure
US8075526B2 (en) 2002-05-24 2011-12-13 Baxter International Inc. Automated dialysis system including a piston and vacuum source
US9775939B2 (en) 2002-05-24 2017-10-03 Baxter International Inc. Peritoneal dialysis systems and methods having graphical user interface
US7153286B2 (en) 2002-05-24 2006-12-26 Baxter International Inc. Automated dialysis system
US20110144569A1 (en) * 2002-05-24 2011-06-16 Baxter International Inc. Peritoneal dialysis machine touch screen user interface
US9814820B2 (en) 2002-07-19 2017-11-14 Baxter International Inc. Weight-controlled sorbent system for hemodialysis
US8992462B2 (en) 2002-07-19 2015-03-31 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US20110106003A1 (en) * 2002-07-19 2011-05-05 Baxter International Inc. Dialysis system and method for cassette-based pumping and valving
US9795729B2 (en) 2002-07-19 2017-10-24 Baxter International Inc. Pumping systems for cassette-based dialysis
US9283312B2 (en) 2002-07-19 2016-03-15 Baxter International Inc. Dialysis system and method for cassette-based pumping and valving
WO2004009156A3 (en) * 2002-07-19 2004-05-06 Baxter Int Systems and methods for peritoneal dialysis
US7208092B2 (en) 2002-07-19 2007-04-24 Baxter International Inc. Systems and methods for peritoneal dialysis
US7922911B2 (en) 2002-07-19 2011-04-12 Baxter International Inc. Systems and methods for peritoneal dialysis
US20040082903A1 (en) * 2002-07-19 2004-04-29 Micheli Brian R. Systems and methods for peritoneal dialysis
US8357113B2 (en) 2002-07-19 2013-01-22 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US20040019320A1 (en) * 2002-07-19 2004-01-29 Childers Robert W. Systems and metods for performing peritoneal dialysis
US9764074B1 (en) 2002-07-19 2017-09-19 Baxter International Inc. Systems and methods for performing dialysis
WO2004009156A2 (en) 2002-07-19 2004-01-29 Baxter International Inc. Systems and methods for peritoneal dialysis
EP2298377A1 (en) 2002-07-19 2011-03-23 Baxter International Inc. Systems and methods for peritoneal dialysis
US10525184B2 (en) 2002-07-19 2020-01-07 Baxter International Inc. Dialysis system and method for pumping and valving according to flow schedule
EP2338543A1 (en) 2002-07-19 2011-06-29 Baxter International Inc. Systems for performing peritoneal dialysis
US7922686B2 (en) 2002-07-19 2011-04-12 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US10179200B2 (en) 2002-07-19 2019-01-15 Baxter International Inc. Disposable cassette and system for dialysis
US20100010429A1 (en) * 2002-07-19 2010-01-14 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US11235094B2 (en) 2002-07-19 2022-02-01 Baxter International Inc. System for peritoneal dialysis
US8597227B2 (en) 2002-07-19 2013-12-03 Baxter International Inc. Weight/sensor-controlled sorbent system for hemodialysis
US8679054B2 (en) 2002-07-19 2014-03-25 Baxter International Inc. Pumping systems for cassette-based dialysis
US11020519B2 (en) 2002-07-19 2021-06-01 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US8998839B2 (en) 2002-07-19 2015-04-07 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US8740837B2 (en) 2002-07-19 2014-06-03 Baxter International Inc. Pumping systems for cassette-based dialysis
US8740836B2 (en) 2002-07-19 2014-06-03 Baxter International Inc. Pumping systems for cassette-based dialysis
US10363352B2 (en) 2002-07-19 2019-07-30 Baxter International Inc. Disposable set and system for dialysis
US8815095B2 (en) 2002-07-19 2014-08-26 Baxter International Inc. Peritoneal dialysis systems and methods that regenerate dialysate
US20090264812A1 (en) * 2002-07-19 2009-10-22 Baxter International Inc. Systems and methods for peritoneal dialysis
US7867214B2 (en) 2002-07-19 2011-01-11 Baxter International Inc. Systems and methods for performing peritoneal dialysis
US20080033346A1 (en) * 2002-12-31 2008-02-07 Baxter International Inc. Pumping systems for cassette-based dialysis
US8206338B2 (en) 2002-12-31 2012-06-26 Baxter International Inc. Pumping systems for cassette-based dialysis
US8900174B2 (en) 2003-10-28 2014-12-02 Baxter International Inc. Peritoneal dialysis machine
US20090281484A1 (en) * 2003-10-28 2009-11-12 Baxter International Inc. Peritoneal dialysis machine
US8070709B2 (en) 2003-10-28 2011-12-06 Baxter International Inc. Peritoneal dialysis machine
US10117986B2 (en) 2003-10-28 2018-11-06 Baxter International Inc. Peritoneal dialysis machine
US9675745B2 (en) 2003-11-05 2017-06-13 Baxter International Inc. Dialysis systems including therapy prescription entries
US20080051696A1 (en) * 2006-03-08 2008-02-28 Conor Curtin Artificial kidney dialysis system
WO2007103411A3 (en) * 2006-03-08 2007-11-01 Fresenius Med Care Hldg Inc Wearable kidney
US8012118B2 (en) 2006-03-08 2011-09-06 Fresenius Medical Care Holdings, Inc. Artificial kidney dialysis system
US20070213665A1 (en) * 2006-03-08 2007-09-13 Conor Curtin Wearable kidney
US8715221B2 (en) 2006-03-08 2014-05-06 Fresenius Medical Care Holdings, Inc. Wearable kidney
US11653945B2 (en) 2007-02-05 2023-05-23 Walk Vascular, Llc Thrombectomy apparatus and method
US9744284B2 (en) 2007-07-05 2017-08-29 Baxter International Inc. Hybrid blood and peritoneal dialysis treatment systems and methods
US10441703B2 (en) 2007-07-05 2019-10-15 Baxter International Inc. Weight controlled and/or sorbent hybrid blood and peritoneal dialysis treatment systems and methods
US11672895B2 (en) 2007-07-05 2023-06-13 Baxter International Inc. Method for peritoneal dialysis and extracorporeal blood treatments
US20090008306A1 (en) * 2007-07-05 2009-01-08 Baxter International Inc. Extracorporeal dialysis ready peritoneal dialysis machine
US8512553B2 (en) 2007-07-05 2013-08-20 Baxter International Inc. Extracorporeal dialysis ready peritoneal dialysis machine
US9227003B2 (en) 2007-07-05 2016-01-05 Baxter International Inc. Hybrid blood and peritoneal dialysis treatment systems and methods
US10434237B2 (en) 2007-07-05 2019-10-08 Baxter International Inc. Hybrid blood and peritoneal dialysis treatment systems and methods
US11045595B2 (en) 2007-07-05 2021-06-29 Baxter International Inc. System for peritoneal dialysis and extracorporeal blood treatments
US20090239821A1 (en) * 2008-03-20 2009-09-24 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US8349813B2 (en) 2008-03-20 2013-01-08 Baxter International Inc. Destruction of microbial products by enzymatic digestion
US8211053B2 (en) 2008-05-13 2012-07-03 Equilibrate, Llc Interosmolar fluid removal
US20090287178A1 (en) * 2008-05-13 2009-11-19 Herbert Curtis B Interosmolar fluid removal
US9697334B2 (en) 2008-07-09 2017-07-04 Baxter International Inc. Dialysis system having approved therapy prescriptions presented for selection
US10646634B2 (en) 2008-07-09 2020-05-12 Baxter International Inc. Dialysis system and disposable set
US9690905B2 (en) 2008-07-09 2017-06-27 Baxter International Inc. Dialysis treatment prescription system and method
US10561780B2 (en) 2008-07-09 2020-02-18 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US9582645B2 (en) 2008-07-09 2017-02-28 Baxter International Inc. Networked dialysis system
US9514283B2 (en) 2008-07-09 2016-12-06 Baxter International Inc. Dialysis system having inventory management including online dextrose mixing
US11400193B2 (en) 2008-08-28 2022-08-02 Baxter International Inc. In-line sensors for dialysis applications
US20100051552A1 (en) * 2008-08-28 2010-03-04 Baxter International Inc. In-line sensors for dialysis applications
US11497521B2 (en) 2008-10-13 2022-11-15 Walk Vascular, Llc Assisted aspiration catheter system
US8777892B2 (en) 2008-11-03 2014-07-15 Fresenius Medical Care Holdings, Inc. Portable peritoneal dialysis system
US20100114012A1 (en) * 2008-11-03 2010-05-06 Sandford Harold F Portable Peritoneal Dialysis System
US20100217179A1 (en) * 2009-02-20 2010-08-26 Baxter International Inc. Bulk delivery peritoneal dialysis system and method
US20100312172A1 (en) * 2009-06-06 2010-12-09 Hoffman Josef C A Method of Peritoneal Dialysis
US20150290384A1 (en) * 2012-11-23 2015-10-15 Triomed Ab Adsorbent for dialysis
US20150273131A1 (en) * 2012-11-23 2015-10-01 Triomed Ab Phosphate and urea adsorption for dialysis
WO2014159918A3 (en) * 2013-03-14 2015-04-16 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US10549023B2 (en) 2013-03-14 2020-02-04 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US11701459B2 (en) 2013-03-14 2023-07-18 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US9440017B2 (en) 2013-03-14 2016-09-13 Baxter International Inc. System and method for performing alternative and sequential blood and peritoneal dialysis modalities
CN105102012A (en) * 2013-03-14 2015-11-25 费森尤斯医疗保健集团 Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US10632243B2 (en) 2013-03-14 2020-04-28 Baxter International Inc. System and method for performing alternative and sequential blood and peritoneal dialysis modalities
US9433720B2 (en) 2013-03-14 2016-09-06 Fresenius Medical Care Holdings, Inc. Universal portable artificial kidney for hemodialysis and peritoneal dialysis
US9913936B2 (en) 2014-04-08 2018-03-13 Incuvate, Llc Systems and methods for management of thrombosis
US9433427B2 (en) 2014-04-08 2016-09-06 Incuvate, Llc Systems and methods for management of thrombosis
US9895473B2 (en) 2014-04-08 2018-02-20 Incuvate, Llc Aspiration monitoring system and method
US10192230B2 (en) 2014-04-08 2019-01-29 Incuvate, Llc Systems and methods for management of thrombosis
US10603415B2 (en) 2014-04-08 2020-03-31 Incuvate, Llc Aspiration monitoring system and method
US9248221B2 (en) 2014-04-08 2016-02-02 Incuvate, Llc Aspiration monitoring system and method
US10922704B2 (en) 2014-04-08 2021-02-16 Incuvate, Llc Systems and methods for management of thrombosis
US11678896B2 (en) 2014-04-08 2023-06-20 Incuvate, Llc Aspiration monitoring system and method
US9883877B2 (en) 2014-05-19 2018-02-06 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US10716583B2 (en) 2014-05-19 2020-07-21 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
WO2015179329A1 (en) * 2014-05-19 2015-11-26 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US11490909B2 (en) 2014-05-19 2022-11-08 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material
US10583237B2 (en) 2014-06-15 2020-03-10 Paragate Medical Ltd. Continuous implantable peritoneal dialysis
WO2015193880A1 (en) * 2014-06-15 2015-12-23 Yair Feld Continuous implantable peritoneal dialysis
US20160008529A1 (en) * 2014-07-11 2016-01-14 Josef C. A. Hoffman Peritoneal Dialysis System and Method
US11495334B2 (en) 2015-06-25 2022-11-08 Gambro Lundia Ab Medical device system and method having a distributed database
US10512713B2 (en) 2015-07-20 2019-12-24 Strataca Systems Limited Method of removing excess fluid from a patient with hemodilution
US11471583B2 (en) 2015-07-20 2022-10-18 Roivios Limited Method of removing excess fluid from a patient with hemodilution
US10918825B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11040180B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Systems, kits and methods for inducing negative pressure to increase renal function
US11040172B2 (en) 2015-07-20 2021-06-22 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10610664B2 (en) 2015-07-20 2020-04-07 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10918827B2 (en) 2015-07-20 2021-02-16 Strataca Systems Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11077284B2 (en) 2015-07-20 2021-08-03 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11918754B2 (en) 2015-07-20 2024-03-05 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11229771B2 (en) 2015-07-20 2022-01-25 Roivios Limited Percutaneous ureteral catheter
US10799668B2 (en) 2015-07-20 2020-10-13 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US11752300B2 (en) 2015-07-20 2023-09-12 Roivios Limited Catheter device and method for inducing negative pressure in a patient's bladder
US11420014B2 (en) 2015-07-20 2022-08-23 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10765834B2 (en) 2015-07-20 2020-09-08 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10926062B2 (en) 2015-07-20 2021-02-23 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US10493232B2 (en) 2015-07-20 2019-12-03 Strataca Systems Limited Ureteral catheters, bladder catheters, systems, kits and methods for inducing negative pressure to increase renal function
US10426919B2 (en) 2015-07-20 2019-10-01 Strataca Systems Limited Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient
US11904113B2 (en) 2015-07-20 2024-02-20 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11904121B2 (en) 2015-07-20 2024-02-20 Roivios Limited Negative pressure therapy system
US11896785B2 (en) 2015-07-20 2024-02-13 Roivios Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11541205B2 (en) 2015-07-20 2023-01-03 Roivios Limited Coated urinary catheter or ureteral stent and method
US11612714B2 (en) 2015-07-20 2023-03-28 Roivios Limited Systems and methods for inducing negative pressure in a portion of a urinary tract of a patient
US10307564B2 (en) 2015-07-20 2019-06-04 Strataca Systems Limited Ureteral and bladder catheters and methods of inducing negative pressure to increase renal perfusion
US11744600B2 (en) 2015-08-28 2023-09-05 Incuvate, Llc Aspiration monitoring system and method
US10702292B2 (en) 2015-08-28 2020-07-07 Incuvate, Llc Aspiration monitoring system and method
US11672561B2 (en) 2015-09-03 2023-06-13 Walk Vascular, Llc Systems and methods for manipulating medical devices
US10561440B2 (en) 2015-09-03 2020-02-18 Vesatek, Llc Systems and methods for manipulating medical devices
US11540847B2 (en) 2015-10-09 2023-01-03 Incuvate, Llc Systems and methods for management of thrombosis
US11051832B2 (en) 2015-12-23 2021-07-06 Incuvate, Llc Aspiration monitoring system and method
US11771445B2 (en) 2015-12-23 2023-10-03 Incuvate, Llc Aspiration monitoring system and method
US10226263B2 (en) 2015-12-23 2019-03-12 Incuvate, Llc Aspiration monitoring system and method
US11510689B2 (en) 2016-04-06 2022-11-29 Walk Vascular, Llc Systems and methods for thrombolysis and delivery of an agent
US11516183B2 (en) 2016-12-21 2022-11-29 Gambro Lundia Ab Medical device system including information technology infrastructure having secure cluster domain supporting external domain
US11844891B2 (en) 2017-05-14 2023-12-19 Paragate Medical Ltd. Implantable fluid extraction system
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
US11678905B2 (en) 2018-07-19 2023-06-20 Walk Vascular, Llc Systems and methods for removal of blood and thrombotic material

Also Published As

Publication number Publication date
JPS528635B1 (en) 1977-03-10
DE2149040A1 (en) 1972-04-06
NL7113434A (en) 1972-04-05
GB1307056A (en) 1973-02-14

Similar Documents

Publication Publication Date Title
US3707967A (en) Steady flow regenerative peritoneal dialysis system and method
US6245039B1 (en) Methods and apparatus for performing flow-through peritoneal dialysis
JP3454824B2 (en) Method for producing and storing a stable bicarbonate solution
CN105120913B (en) Sodium and buffer solution source capsule for the controlled compatible stream of modularization
US4911717A (en) Intravasular artificial organ
CN104968376B (en) For delivering the fluid circuit of renal replacement therapy
US4239041A (en) Method for continuous ambulatory peritoneal dialysis
US5037385A (en) Continuous ambulatory peritoneal dialysis method
CN105025951B (en) For the system and method for multi-functional volume fluid control
ES2559667T3 (en) Ultrafiltration apparatus comprising a long peripheral access venous cannula for blood collection
US8202248B2 (en) Dialysis implant and methods of use
JPS5892360A (en) Apparatus for skin transplantation
JP2004529666A (en) Prosthesis for peritoneal dialysis and method of performing peritoneal dialysis
GB1601223A (en) Method and apparatus for continuous ambulatory peritoneal dialysis
US20020052571A1 (en) Artificial kidney and methods of using same
US3864259A (en) Ambulatory hemodialysis apparatus
EP0084552A1 (en) Conduit connectors having antiseptic application means.
Cantaluppi et al. Peritonitis Prevention in Continuous Ambulatory Peritoneal Dialysis: Long Term Efficacy of a Y-Connector and Disinfectant
Bazaev et al. A wearable device for low-flow detoxification of human body by peritoneal dialysis
Munib Continuous ambulatory peritoneal dialysis (CAPD)
US20210369930A1 (en) Combination wearable and stationary dialysis system with ultrafiltrate module
JP2629084B2 (en) Preservation method of membrane oxygenator
Bellinghieri et al. Exhaustion of vascular endowment in hemodialysis: proposal for a permanent inlet access
RO125509A0 (en) Set of elements and peritoneal filtration method
Bazaev et al. A wearable device for continuous automated peritoneal dialysis with dialysis− sorption regeneration of the dialysis fluid

Legal Events

Date Code Title Description
AS Assignment

Owner name: CROCKER NATIONAL BANK, ONE MONTGOMERY ST., SAN FRA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:THORATEC LABORATORIES CORPORATION A CA CORP.;REEL/FRAME:004066/0838

Effective date: 19821201

AS Assignment

Owner name: CROCKER NATIONAL BANK,CALIFORNIA

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION A CA CORP;REEL/FRAME:004339/0427

Effective date: 19841207

Owner name: CROCKER NATIONAL BANK ONE MONTGOMERY ST., SAN FRAN

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION A CA CORP;REEL/FRAME:004339/0427

Effective date: 19841207

AS Assignment

Owner name: WELLS FARGO BANK N.A., 420 MONTGOMERY STREET, SAN

Free format text: SECURITY INTEREST;ASSIGNORS:THORATEC LABORATORIES INCORPORATED;THORATEC MEDICAL INCORPORATED;BIOTEX INDUSTRIES INCORPORATED MERCOR INCORPORATED;REEL/FRAME:004681/0966

Effective date: 19870122

AS Assignment

Owner name: BRADLEY RESOURCES COMPANY, A NEW YORK GENERAL PART

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CORP. OF CA.;REEL/FRAME:005049/0326

Effective date: 19880616

Owner name: BELL, CHRISTY W.

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CORP. OF CA.;REEL/FRAME:005049/0326

Effective date: 19880616

Owner name: GLENN, PAUL F.

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CORP. OF CA.;REEL/FRAME:005049/0326

Effective date: 19880616

AS Assignment

Owner name: BRADLEY RESOURCES COMPANY ("BRADLEY"), A NEW YORK

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CA CORP.;REEL/FRAME:004926/0506

Effective date: 19880616

Owner name: BELL, CHRISTY W., ( BELL )

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CA CORP.;REEL/FRAME:004926/0506

Effective date: 19880616

Owner name: GLENN, PAUL F., ( GLENN )

Free format text: SECURITY INTEREST;ASSIGNOR:THORATEC LABORATORIES CORPORATION, A CA CORP.;REEL/FRAME:004926/0506

Effective date: 19880616

AS Assignment

Owner name: HILL, J. DONALD

Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202

Effective date: 19890628

Owner name: GLENN, PAUL F.

Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202

Effective date: 19890628

Owner name: BELL, CHRISTY W.

Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202

Effective date: 19890628

Owner name: BRADLEY RESOURCES COMPANY

Free format text: SECURITY INTEREST;ASSIGNOR:WELLS FARGO BANK N.A., A NATIONAL BANKING ASSOCIATION;REEL/FRAME:005250/0202

Effective date: 19890628